Preeclampsia Foundation Backs PREEMPT Act to Improve Access to Early Risk Testing – Preeclampsia Foundation
Preeclampsia Foundation shared a post on LinkedIn:
“The Preeclampsia Foundation is excited to announce the introduction of H.R. 9061, the Preeclampsia Risk Evaluation and Evidence-based Management through Personalized Testing Act or PREEMPT Act. The bipartisan legislation would ensure state Medicaid programs receive needed information about new innovative testing available to identify pregnant women at risk of or experiencing early signs of preeclampsia at all phases of pregnancy.
‘The Preeclampsia Foundation is excited by the promise of advanced biomarker tests to transform pregnancy care across all trimesters – helping providers identify preeclampsia earlier, tailor care, and potentially prevent devastating outcomes for mothers and babies. It is especially important that state Medicaid and CHIP programs are aware of and informed about these new tools, given the higher proportion of high‑risk women they serve, so that enrolled pregnant women can benefit from their availability. We will work to advance this important bill this year,’ said Eleni Tsigas, CEO, Preeclampsia Foundation.
The Foundation works with Congress, maternal health advocates, clinicians, and state Medicaid leaders to accelerate access to tools and technologies that improve the care of pregnant and postpartum women and reduce maternal morbidity and mortality in the United States.
Learn more at the press release here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 19, 2026, 05:52Join the Global Conversation on Reproductive Medicine! – ESHRE
-
Jul 19, 2026, 05:51Mays Aladham: Inspiring How ESHRE Gathers Us Every Year From Across the Globe on One Platform!
-
Jul 19, 2026, 05:48Strengthening Primary Care Partnerships Through Clinical Education – City Fertility
-
Jul 19, 2026, 05:47Marco Zaccaria: 3 Essential Steps to Manage Uterine Fibroids!
-
Jul 19, 2026, 05:45PGT-A Integration Into PGT-M Protocols in Young ART-Naïve Patients – RBMO
-
Jul 19, 2026, 05:41ELTA 90 MG Explores the Future of IVF at ESHRE 2026 – Elta 90 Medical Genetics
-
Jul 18, 2026, 07:55Ahmed Fahim Hemaid: Starting New Role as Consultant Obstetrician and Gynaecologist at Great Western Hospital
-
Jul 18, 2026, 07:52Suganya Venkat: How the 2002 Hormone Therapy Study Changed Menopause Care
-
Jul 18, 2026, 07:50Paras Yadav: Why Uterine Aging Matters in Fertility and IVF Outcomes?